Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- smallpox vaccine
Interactions between your drugs
smallpox vaccine SARS-CoV-2 (COVID-19) NVX-CoV2373 vaccine, recombinant
Applies to: smallpox vaccine, sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
Vaccination with smallpox vaccine and SARS-CoV-2 (COVID-19) NVX-CoV2373 vaccine, recombinant at the same time or within a short time of each other may increase the risk of myopericarditis, or inflammation of the heart muscle and lining of the heart. These vaccines individually may be associated with a rare risk of developing myopericarditis, but the risk may be greater when they are administered together, particularly in adolescent or young adult males. If feasible, it may be advisable to wait 4 weeks in between the two vaccines, unless there is an outbreak that requires prompt vaccination. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Paxlovid
PAXLOVID (nirmatrelvir with ritonavir) is an antiviral medication used to treat COVID-19. Includes ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Olumiant
Olumiant is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes ...
Anakinra
Anakinra is used for COVID-19, cryopyrin-associated periodic syndromes, interleukin-1 receptor ...
Baricitinib
Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, alopecia areata (hair ...
Molnupiravir
Molnupiravir is an experimental medicine being studied for the treatment of mild-to-moderate ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.